Acorah Software Products - Accounts Production16.8.200falsetruefalsetrueNo description of principal activity1 June 202431 March 202531 March 202507251114Mr Kojo Amoako-WireduMr Kwadwo Amoako-WireduMr Kwadwo Amoako-Wireduiso4217:GBPiso4217:EURiso4217:USDxbrli:sharesxbrli:purexbrli:pure072511142024-05-31072511142025-03-31072511142024-06-012025-03-3107251114frs-core:CurrentFinancialInstruments2025-03-3107251114frs-bus:PrivateLimitedCompanyLtd2024-06-012025-03-3107251114frs-bus:FilletedAccounts2024-06-012025-03-3107251114frs-bus:Micro-entities2024-06-012025-03-3107251114frs-bus:AuditExempt-NoAccountantsReport2024-06-012025-03-3107251114frs-bus:Director12024-06-012025-03-3107251114frs-bus:Director22024-06-012025-03-3107251114frs-bus:CompanySecretary12024-06-012025-03-31
Registered number: 07251114
Kaizen Pharma Limited
Unaudited Financial Statements
For the Period 1 June 2024 to 31 March 2025
TaxAssist Accountants
476 St. Albans Road
Watford
WD24 6QU
Kaizen Pharma Limited
Balance Sheet
As At 31 March 2025
Balance Sheet
Registered number: 07251114
31 March 2025
£
Current assets
4,330
Creditors: Amounts Falling Due Within One Year
30,512
NET CURRENT ASSETS
34,842
TOTAL ASSETS LESS CURRENT LIABILITIES
34,842
Accruals and deferred income
(392)
NET ASSETS
34,450
CAPITAL AND RESERVES
34,450
Notes
1.General Information
Kaizen Pharma Limited is a private company, limited by shares, incorporated in England & Wales, registered number 07251114. The registered office is Unit 9 11 Main Drive, East Lane, Wembley, HA9 7ND.
2.Average Number of Employees
Average number of employees, including directors, during the period was: NIL
-
For the period ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.